For a broader research view, use Synapse Hiro LS Researcherthe Synapse AI Insight Engineto search across drugs, targets, indications, clinical trials, literature, organizations, news, deals, and competitor signals
We prioritize these standards by partnering with only reputable, high-quality compounding pharmacies
This stepped approach allows your body to tolerate the medication while minimizing side effects
PubMed Central , Accessed 9 Apr
SLC1A5 The amino acid transporter SLC1A5 (ASCT 2) is highly expressed in various tumor tissues and is associated with poor prognosis of cancer
After 4 weeks, your provider will raise your dose to 5 mg injected once weekly